Xvivo Perfusion AB (publ) (STO:XVIVO)

Market Cap	5.67B -60.7%
Revenue (ttm)	812.17M -1.2%
Net Income	25.16M -85.4%
EPS	0.80 -85.3%
Shares Out	31.50M
PE Ratio	225.33
Forward PE	53.57
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,838
Average Volume	121,216
Open	182.10
Previous Close	187.50
Day's Range	178.90 - 184.00
52-Week Range	160.00 - 444.50
Beta	1.89
RSI	42.63
Earnings Date	Apr 24, 2026

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 198
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: XVIVO

Financial Performance

In 2025, Xvivo Perfusion AB's revenue was 812.17 million, a decrease of -1.25% compared to the previous year's 822.42 million. Earnings were 25.16 million, a decrease of -85.39%.